KANNER DOV 4/A
4/A · SAVIENT PHARMACEUTICALS INC · Filed Aug 4, 2003
Insider Transaction Report
Form 4/AAmended
KANNER DOV
Executive Vice President
Transactions
- Award
Common stock, $.01 par value per share
2003-08-01$4.46/sh−2,897$12,912→ 5,397 total - Disposition to Issuer
Common stock, $.01 par value per share
2003-08-01$4.46/sh−2,897$12,912→ 2,500 total
Footnotes (2)
- [F1]Consists of shares acquired pursuant to Savient Pharmaceuticals, Inc. Employee Stock Purchase Plan
- [F2]Acquisition price incorrectly reported as the disposition price in the previously filed Form 4